Yeji
CRLconf 0.90

reproxalap — CRL

$ALDX · Aldeyra Therapeutics, Inc. · dry eye disease
Event date
Date TBD
Sponsor runway
38 mo
$65.0M liquid

Evidence

“Aldeyra Received a Complete Response Letter for Reproxalap for the Treatment of Dry Eye Disease The Complete Response Letter stated that the NDA ”
Source: Press release · 2025-04-03View press release ↗

Comparable historical crls· last 5 years · same event type

No comparable historical outcomes in our database yet — backfill of past readouts arrives next ingestion cycle.

Recent insider activity· ±90 days

No insider Form 4 activity reported on $ALDX in the 90 days around this event.
← All catalysts for $ALDX